Speaker illustration

Doctor Marzia Rigolli

Global Drug Development, San Diego (United States of America)

Member of:

Heart Failure Association

Dr. Rigolli is a Cardiologist, Physician-Scientist (MD, DPhil), Director of Cardiovascular Global Drug Development with expertise in Cardiovascular Imaging, Cardiomyopathies, Heart Failure and Valvular Heart Disease. She trained in Cardiovascular Medicine at the University of Verona, Italy, and at the University of Oxford, United Kingdom. Dr. Rigolli obtained highest expert qualifications in CMR and CT after multi-modality imaging fellowships in Oxford, UK and Auckland, NZ. Her doctoral studies were awarded a DPhil (PhD) from the University of Oxford in 2019 before moving to the US to work on Rare Diseases and Imaging at the University of California, San Diego. Her academic research examined the role of imaging in assessing clinical outcomes and treatment targets. Dr. Rigolli is currently developing drugs in cardiomyopathies (HCM) and Heart Failure. She is passionate about clinical trials, publishes in high-impact journals, and has won multiple young investigator awards.

Cardiomyopathy phenotyping and risk-stratification in danon disease

Event: ESC Congress 2020

Topic: Myocardial Disease

Session: Latest Advances in Cardiac Magnetic Resonance


Right ventricular dysfunction is associated with late mortality in severe aortic stenosis: results from a multi-centre outcome study in patients undergoing aortic valve replacement

Event: ESC Congress 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Imaging parameters in valvular heart disease


Right ventricular dysfunction detected by cardiovascular magnetic resonance is associated with late mortality in severe aortic stenosis

Event: EuroCMR 2019

Topic: Valvular Heart Disease

Session: Rapid Fire Abstract 6: 4D flow and valvular heart disease: can CMR add value?


COPD in symptomatic aortic stenosis: the importance of correct assessment for defining prognosis

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Prognosis in aortic stenosis


Accuracy and inter-changeability in left ventricular quantification by multi-modality imaging: a systematic review and meta-analysis.

Event: ESC Congress 2016

Topic: Multimodality / hybrid imaging, other imaging

Session: Multi-modality imaging


ESC 365 is supported by

logo Novo Nordisk